(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var | |
| Sales | 36.62 | 44.75 | -18.17 | 115.68 | 147.20 | -21.41 | 223.62 | 137.40 | 62.75 |
| Other Income | 1.16 | 0.99 | 17.17 | 1.55 | 1.74 | -10.92 | 5.22 | 4.60 | 13.48 |
| PBIDT | 1.70 | 2.00 | -15.00 | 5.11 | 7.91 | -35.40 | 9.81 | 8.17 | 20.07 |
| Interest | 0.01 | 0.03 | -66.67 | 0.06 | 0.10 | -40.00 | 0.13 | 0.09 | 44.44 |
| PBDT | 1.69 | 1.93 | -12.44 | 5.05 | 7.77 | -35.01 | 9.64 | 8.08 | 19.31 |
| Depreciation | 0.66 | 0.96 | -31.25 | 2.07 | 2.61 | -20.69 | 3.58 | 2.50 | 43.20 |
| PBT | 1.03 | 0.97 | 6.19 | 2.98 | 5.16 | -42.25 | 6.06 | 5.58 | 8.60 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.95 | 1.18 | 150.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.13 | -0.16 | -806.25 |
| PAT | 1.03 | 0.97 | 6.19 | 2.98 | 5.16 | -42.25 | 3.11 | 4.40 | -29.32 |
| Equity | 53.74 | 53.74 | 0.00 | 53.74 | 53.74 | 0.00 | 53.74 | 53.74 | 0.00 |
| PBIDTM(%) | 4.64 | 4.47 | 3.87 | 4.42 | 5.37 | -17.79 | 4.39 | 5.95 | -26.22 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1850.40 |
| Dr. Reddys Lab | 1310.50 |
| Cipla | 1365.25 |
| Zydus Lifesciences | 939.10 |
| Lupin | 2442.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: